Skip to main content

Eagle Pharmaceuticals Inc (NASDAQ: EGRX) Investor Securities Class Action Lawsuit 05/31/2016

  • If you purchased shares of Eagle Pharmaceuticals Inc (NASDAQ: EGRX), you may have certain options. Please contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

August 3, 2017- The court granted defendants' motion to dismiss. December 16, 2016 - A motion to dismiss the amended complaint was filed. October 31, 2016 - An amended complaint was filed. May 31, 2016 - An investor in shares of Eagle Pharmaceuticals Inc (NASDAQ: EGRX) filed a lawsuit in the U.S. District Court for the District of New Jersey over alleged violations of Federal Securiti...



You must register (for free) or login to view the entire case.